Join Lombardi in the Infinite Power of One Campaign
Lombardi has joined with 11 of the nation's top cancer centers to launch the Infinite Power of One Campaign. These 12 centers, all NCI-designated comprehensive cancer centers, aligned to empower all people to work together to change the face of cancer today. We believe that if we exercise our Infinite Power of One, we can accelerate cancer research and lessen the deadly impact of this disease. It is proof that together, we are more powerful than cancer. Read a letter from Lombardi's Director...
|
In the Spotlight
|
|
Newly Funded Grants
Edgar Diaz-Cruz, PhD, received a $225,000 grant from Susan G. Komen for the Cure to study the interaction between estrogen signaling pathways and p53 in breast cancer.
Habtom Ressom, PhD, received an $80,000 grant from the Prevent Cancer Foundation to identify serum biomarkers for early detection of liver cancer.
Stephen Byers, PhD, received a $1.6 million R01 from the NCI to study beta-catenin-specific regulation of the vitamin D pathway in colon cancer.
More grants...
|
|
|
Lombardi in the News
Recent Papers
Habtom Ressom published a paper on identification of transcription factor-target gene relationships in BMC Bioinformatics.
Louis Weiner published a paper on blocking NK cell inhibitory self-recognition in a model of anti-lymphoma therapy in J Immunol.
Carolyn Hurley published a paper on the HLA type of EBV-transformed human B cell lines in Current Protoc Immunol.
More papers...
|
|